POTTERS BAR, England,
April 27, 2015 /PRNewswire/
-- Mylan N.V. (NASDAQ: MYL) announced today that it will host
a conference call and live webcast on Tuesday, May 5, 2015, at 4:30 p.m. ET, to review the company's financial
results for the first quarter ended March
31, 2015 and to provide an update on the proposed
acquisition of Perrigo. Mylan will release its financial results on
May 5 after the market closes.
The dial-in number to access the call is 800.514.4861 or
678.809.2405 for international callers. To access the live webcast,
please log on to Mylan's website, mylan.com, at least 15 minutes
before the event is scheduled to begin to register and download or
install any necessary software. A replay of the webcast will be
available at mylan.com/investors, for a limited time.
Mylan is a global pharmaceutical company committed to setting
new standards in healthcare. Working together around the world to
provide 7 billion people access to high quality medicine, we
innovate to satisfy unmet needs; make reliability and service
excellence a habit; do what's right, not what's easy; and impact
the future through passionate global leadership. We offer a growing
portfolio of around 1,400 generic pharmaceuticals and several brand
medications. In addition, we offer a wide range of antiretroviral
therapies, upon which approximately 40% of HIV/AIDS patients in
developing countries depend. We also operate one of the largest
active pharmaceutical ingredient manufacturers and currently market
products in about 145 countries and territories. Our workforce of
approximately 30,000 people is dedicated to creating better health
for a better world, one person at a time. Learn more at
mylan.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/mylan-schedules-first-quarter-2015-financial-results-conference-call-and-live-webcast-300072521.html
SOURCE Mylan N.V.